Μαρία Αθανασίου

26.3k total citations
36 papers, 1.3k citations indexed

About

Μαρία Αθανασίου is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Μαρία Αθανασίου has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Psychiatry and Mental health. Recurrent topics in Μαρία Αθανασίου's work include Treatment of Major Depression (7 papers), Schizophrenia research and treatment (4 papers) and Bipolar Disorder and Treatment (4 papers). Μαρία Αθανασίου is often cited by papers focused on Treatment of Major Depression (7 papers), Schizophrenia research and treatment (4 papers) and Bipolar Disorder and Treatment (4 papers). Μαρία Αθανασίου collaborates with scholars based in United States, Greece and Netherlands. Μαρία Αθανασίου's co-authors include Carol R. Reed, Heidi Whalen, Anil K. Malhotra, Leonidas Gregorakos, H Apostolakos, Ioannis Alamanos, Νικόλαος Μάρκου, Konstantina S. Nikita, Donald S. Robinson and John M. Kane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Μαρία Αθανασίου

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Μαρία Αθανασίου United States 18 378 255 213 196 188 36 1.3k
Olivier Blin France 21 237 0.6× 404 1.6× 78 0.4× 53 0.3× 290 1.5× 88 2.4k
Omar Ali United States 19 135 0.4× 644 2.5× 77 0.4× 77 0.4× 104 0.6× 39 1.4k
John A. Bilello United States 27 181 0.5× 93 0.4× 148 0.7× 61 0.3× 351 1.9× 54 2.1k
Joseph J. Meissler United States 25 324 0.9× 141 0.6× 33 0.2× 82 0.4× 429 2.3× 54 1.7k
Malin Jonsson Fagerlund Sweden 24 104 0.3× 108 0.4× 75 0.4× 50 0.3× 353 1.9× 82 2.0k
Vanessa Bloch France 16 123 0.3× 104 0.4× 145 0.7× 33 0.2× 202 1.1× 72 841
Jing Shi China 23 108 0.3× 241 0.9× 50 0.2× 39 0.2× 355 1.9× 134 1.7k
Wayne S. Schwark United States 23 710 1.9× 255 1.0× 157 0.7× 91 0.5× 364 1.9× 84 1.9k
Jaya Kumar Malaysia 21 135 0.4× 106 0.4× 39 0.2× 20 0.1× 310 1.6× 78 1.6k

Countries citing papers authored by Μαρία Αθανασίου

Since Specialization
Citations

This map shows the geographic impact of Μαρία Αθανασίου's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Μαρία Αθανασίου with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Μαρία Αθανασίου more than expected).

Fields of papers citing papers by Μαρία Αθανασίου

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Μαρία Αθανασίου. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Μαρία Αθανασίου. The network helps show where Μαρία Αθανασίου may publish in the future.

Co-authorship network of co-authors of Μαρία Αθανασίου

This figure shows the co-authorship network connecting the top 25 collaborators of Μαρία Αθανασίου. A scholar is included among the top collaborators of Μαρία Αθανασίου based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Μαρία Αθανασίου. Μαρία Αθανασίου is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Αθανασίου, Μαρία, et al.. (2025). A comprehensive interpretable machine learning framework for mild cognitive impairment and Alzheimer’s disease diagnosis. Scientific Reports. 15(1). 8410–8410. 5 indexed citations
4.
Αθανασίου, Μαρία, et al.. (2025). A Comprehensive Drift-Adaptive Framework for Sustaining Model Performance in COVID-19 Detection From Dynamic Cough Audio Data: Model Development and Validation. Journal of Medical Internet Research. 27. e66919–e66919.
5.
6.
7.
Chan, Candace S. Y., Μαρία Αθανασίου, Anastasios D. Papanastasiou, et al.. (2024). Utilizing nullomers in cell-free RNA for early cancer detection. Cancer Gene Therapy. 31(6). 861–870. 6 indexed citations
8.
Zarkogianni, Konstantia, Nektaria Polychronaki, Nicolas C. Nicolaides, et al.. (2023). The ENDORSE Feasibility Study: Exploring the Use of M-Health, Artificial Intelligence and Serious Games for the Management of Childhood Obesity. Nutrients. 15(6). 1451–1451. 14 indexed citations
9.
Kiourti, Asimina, Amin Abbosh, Μαρία Αθανασίου, et al.. (2022). Next-Generation Healthcare: Enabling Technologies for Emerging Bioelectromagnetics Applications. IEEE Open Journal of Antennas and Propagation. 3. 363–390. 37 indexed citations
10.
Αθανασίου, Μαρία, et al.. (2022). Long Short-term Memory–Based Prediction of the Spread of Influenza-Like Illness Leveraging Surveillance, Weather, and Twitter Data: Model Development and Validation. Journal of Medical Internet Research. 25. e42519–e42519. 17 indexed citations
11.
12.
Ashby, Charles R., John H. Kehne, Gerd D. Bartoszyk, et al.. (2013). Electrophysiological evidence for rapid 5-HT1A autoreceptor inhibition by vilazodone, a 5-HT1A receptor partial agonist and 5-HT reuptake inhibitor. European Journal of Pharmacology. 714(1-3). 359–365. 24 indexed citations
13.
Reed, Carol R., et al.. (2011). The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder. Current Medical Research and Opinion. 28(1). 27–39. 20 indexed citations
14.
Khan, Arif, Andrew J. Cutler, Daniel K. Kajdasz, et al.. (2011). A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 72(4). 441–447. 106 indexed citations
15.
Αθανασίου, Μαρία, Michael Dettling, Ingolf Cascorbi, et al.. (2010). Candidate Gene Analysis Identifies a Polymorphism inHLA-DQB1Associated With Clozapine-Induced Agranulocytosis. The Journal of Clinical Psychiatry. 72(4). 458–463. 87 indexed citations
16.
Rickels, Karl, Μαρία Αθανασίου, Donald S. Robinson, et al.. (2009). Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 70(3). 326–333. 115 indexed citations
17.
Μάρκου, Νικόλαος, et al.. (2003). Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Critical Care. 7(5). R78–83. 233 indexed citations
18.
Takada, Toyoyuki, Attila Kumánovics, Claire Amadou, et al.. (2003). Species-Specific Class I Gene Expansions Formed the Telomeric 1 Mb of the Mouse Major Histocompatibility Complex. Genome Research. 13(4). 589–600. 22 indexed citations
19.
Schmidt, Cynthia, et al.. (1993). Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 23 indexed citations
20.
Schmidt, Cynthia, Μαρία Αθανασίου, Lisa Duvick, et al.. (1993). Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription.. The Journal of Immunology. 151(5). 2633–2645. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Blin Breakdown of academic impact, for papers by Omar Ali Breakdown of academic impact, for papers by John A. Bilello Breakdown of academic impact, for papers by Joseph J. Meissler Breakdown of academic impact, for papers by Malin Jonsson Fagerlund Breakdown of academic impact, for papers by Vanessa Bloch Breakdown of academic impact, for papers by Jing Shi Breakdown of academic impact, for papers by Wayne S. Schwark Breakdown of academic impact, for papers by Jaya Kumar
Rankless by CCL
2026